Homocysteine-lowering interventions are ineffective in preventing myocardial infarction.

Int J Cardiol

Department of Neurological and Movement Sciences, Section of Clinical Neurology, University of Verona, Italy; Division of Neurology, Franz Tappeiner Hospital, Merano, Italy. Electronic address:

Published: October 2013

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijcard.2013.07.208DOI Listing

Publication Analysis

Top Keywords

homocysteine-lowering interventions
4
interventions ineffective
4
ineffective preventing
4
preventing myocardial
4
myocardial infarction
4
homocysteine-lowering
1
ineffective
1
preventing
1
myocardial
1
infarction
1

Similar Publications

Objective: This study aimed to investigate the prognostic impact of serum homocysteine-lowering therapy on patients with hemorrhagic stroke (HS) and its influence on their National Institutes of Health Stroke Scale (NIHSS) and China Stroke Scale (CSS) scores.

Methods: A double-blind study involving 120 patients with HS and hyperhomocysteinemia (Hhcy) who were admitted to our hospital was conducted in 2021. They were evenly divided into two groups: the control group (n=60) received low-dose folic acid, methylcobalamin, and vitamin B6 as part of serum homocysteine-lowering therapy, while the study group (n=60) received high-dose folic acid, methylcobalamin, and vitamin B6.

View Article and Find Full Text PDF

Purpose: Homocysteine (Hcy) is recognized as a risk factor for stroke. Our study examined the relationship between plasma Hcy levels and stroke, along with its subtypes, among Chinese patients who experienced an acute stroke episode.

Patients And Methods: We retrospectively enrolled patients with acute stroke and age- and sex-matched healthy controls admitted to the First Affiliated Hospital of Xi'an Jiaotong University from October 2021 to September 2022.

View Article and Find Full Text PDF

Introduction: Statins and fibrates are two lipid-lowering drugs used in patients with dyslipidemia. This systematic review and meta-analysis were conducted to determine the magnitude of the effect of statin and fibrate therapy on serum homocysteine levels.

Methods: A search was undertaken of the PubMed, Scopus, Web of Science, Embase, and Google Scholar electronic databases up to 15 July 2022.

View Article and Find Full Text PDF

Homocysteine, inversely related to folate and vitamin B12, is an independent risk factor for several age-related disorders. However, little is known about the association of homocysteine and related vitamins with osteoarthritis (OA). This study aimed to elucidate the potential causal effects of homocysteine, folate, and vitamin B12 on site- and gender-specific OA by applying the two-sample Mendelian randomization (MR) approach.

View Article and Find Full Text PDF

Plasma homocysteine levels and risk of congestive heart failure or cardiomyopathy: A Mendelian randomization study.

Front Cardiovasc Med

January 2023

National Clinical Research Center for Chinese Medicine Cardiology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.

Background: Although observational studies have demonstrated associations between elevated plasma homocysteine levels and the risk of cardiovascular diseases, controversy remains.

Objective: This study investigated the causal association of plasma homocysteine levels with congestive heart failure and cardiomyopathy risk.

Methods: We performed a two-sample Mendelian randomization (MR) study of congestive heart failure ( = 218,792), cardiomyopathy ( = 159,811), and non-ischemic cardiomyopathy ( = 187,152).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!